Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.09 | N/A |
| PEG Ratio (TTM) | -14.87 | N/A |
| P/S Ratio (TTM) | 1.12 | N/A |
| P/B Ratio (TTM) | 2.06 | N/A |
| P/FCF Ratio (TTM) | 6.41 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.21 | N/A |
| Price to 5YR AVG FCF Ratio | 47.31 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.35% | N/A |
| ROE (TTM) | 11.83% | N/A |
| Net Profit Margin (TTM) | 6.16% | N/A |
| ROIC 5YR AVG | 19.07% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.74% | 19.96% | 14.03% |
| Revenue | -19.82% | 10.19% | 10.16% |
| Net Income | 0.75% | 19.65% | 13.80% |
| Cash Flow | 43.85% | -43.16% | 321.24% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.85 | N/A |
| Quick Ratio (TTM) | 1.71 | N/A |
| D/E Ratio (TTM) | 0.16 | N/A |
| Interest Coverage (TTM) | 50.66 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 3.95 | N/A |
| LTL to 5YR AVG FCF | 0.31 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.21% | N/A |